DEF 14AThe Ballot
Aclaris Therapeutics, Inc. files DEF 14A
Filed Apr 26, 2018 · 8y ago · Accession 0001558370-18-003338
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- DEF 14A
- Filing date
- Apr 26, 2018
- Report date
- Jun 7, 2018
- Document
- def14a.htm
- Size
- 967 KB